Cargando…
Speaker 4: Michael Berk
Autores principales: | M, Berk, A, Turner, GS, Malhi, C, Ng, SM, Cotton, S, Dodd, J, Sarris, Y, Samuni, M, Tanious, N, Dowling, A, Waterdrinker, D, Smith, OM, Dean |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616585/ http://dx.doi.org/10.1093/ijnp/pyw042.109 |
Ejemplares similares
-
Speaker 3: Michael Berk, Australia
por: Michael, Berk, et al.
Publicado: (2016) -
Speaker 2: Olivia Dean, Australia
por: OM, Dean, et al.
Publicado: (2016) -
A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo
por: Berk, Michael, et al.
Publicado: (2019) -
Correction to: A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo
por: Berk, Michael, et al.
Publicado: (2019) -
Mixed Methods Thematic Analysis of a Randomised Controlled Trial of Adjunctive Mitochondrial Agents for Bipolar Depression
por: Russell, Samantha E., et al.
Publicado: (2022)